2013

Husch Blackwell partner Carlos Rodriguez‘s article, “Ocean Transportation Intermediaries in the Cross-Fire,” appeared in the New York New Jersey Foreign Freight Forwarders and Brokers Association Inc. Newsletter, Fall/Winter 2013. Carlos concentrates his practice in international and domestic transportation law. He skillfully navigates his maritime clients through the complexities of regulation and…

Three of the world’s largest steamship companies serving Asia, Europe and the United States have submitted  an important vessel sharing agreement to the Federal Maritime Commission for approval. The net effect of this filing, if gone unchallenged, would be to provide these three carriers with anti-trust immunity for implementing certain practices normally in violation of anti-trust statutes. The Federal Maritime Commission said it would accept public comment on the “P3 Network Vessel Sharing Agreement” of Maersk, Mediterranean Shipping and CMA CGM until midnight Friday, Nov. 29. Current law provides that if the commission takes no action to seek an injunction or require additional information, the agreement will become effective 45 days after the original filing date of Oct. 24, i.e., on Dec. 8.

The International Supply Chain Going Into 2014 seminar is focused on international trade transactions. After one afternoon of targeted training with Husch Blackwell, MIQ Logistics and JPMorgan Chase, participants will have a better understanding of the following issues that affect businesses like yours every day:

  • Overview of the Supply Chain
  • Payment and Banking Issues
  • Review

…

There was a time when the decision to offshore manufacturing operations to an emerging market was an easy business decision.  However, the past decade has many companies questioning that business model.  Rising labor costs, uncertain supply chains, labor unrest and the costly and lengthy delivery time for manufactured goods coming from Asia has exponentially increased the cost to offshore manufacturing.

On Aug 5, 2013, the China Food and Drug Administration (CFDA) opened its draft Rules of the China Food and Drug Administration Legislation Procedure (the “Draft”) for public comment. The CFDA provided one month (August 5-September 5) to submit opinions on the new rules in the Draft. The Draft states the purposes of the new Rules are to regulate legislative procedures, guarantee the quality of legislation, and improve the efficiency of the legislation.